ReviewJournal of nanobiotechnology2025
Functions and applications of enzymes in nucleic acid nanotechnology.
Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Nucleic acid nanotechnology (NAN) has emerged as a powerful platform for constructing programmable molecular architectures, with broad applications spanning biomedicine, materials science, and molecular computing. While numerous reviews have covered the design principles and functional modalities of enzyme-free NAN systems, a comprehensive framework for understanding enzyme-involved NAN remains conspicuously absent. Given the growing interest in enzyme-involved systems, enzymes offer distinct advantages to NAN, including enhanced programmability, dynamic control, and expanded functional versatility. This review addresses that gap by systematically categorizing the enzymatic toolkit-including polymerases, modifying enzymes, endo-/exonucleases, ligases, other protein-based enzymes, as well as nucleic acid enzymes such as DNAzymes, ribozymes, and XNAzymes-and elucidating their roles in enabling structural assembly and dynamic control at the molecular level. Enzymes function not only as assembly agents for nucleic acid nanostructures, facilitating strand extension, ligation, cleavage, and chemical modification, but also as essential driver tools mediating degradation, release, and template-guided polymerization. Their integration has led to highly adaptive and reconfigurable systems with capabilities far surpassing enzyme-free counterparts. We further highlight key advances in enzyme-powered NAN across diverse frontiers, including in vitro diagnostics (IVD), cellular and in vivo imaging, DNA data storage and computing, biomimetic material synthesis, and drug delivery. By mapping catalytic mechanisms to functional outputs, and identifying current bottlenecks in specificity, modularity, and integration, this review establishes a unified conceptual foundation and design roadmap for the next generation of enzyme-driven nucleic acid nanodevices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.